GR75053B - - Google Patents

Info

Publication number
GR75053B
GR75053B GR66121A GR810166121A GR75053B GR 75053 B GR75053 B GR 75053B GR 66121 A GR66121 A GR 66121A GR 810166121 A GR810166121 A GR 810166121A GR 75053 B GR75053 B GR 75053B
Authority
GR
Greece
Prior art keywords
chlorosulfonyl
imide
symptoms
inhibiting
bis
Prior art date
Application number
GR66121A
Other languages
English (en)
Inventor
Fadia Elfehall Ali
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of GR75053B publication Critical patent/GR75053B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR66121A 1980-09-26 1981-09-23 GR75053B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/191,644 US4321254A (en) 1980-09-26 1980-09-26 Antiallergic imidodisulfamides

Publications (1)

Publication Number Publication Date
GR75053B true GR75053B (el) 1984-07-13

Family

ID=22706323

Family Applications (1)

Application Number Title Priority Date Filing Date
GR66121A GR75053B (el) 1980-09-26 1981-09-23

Country Status (8)

Country Link
US (1) US4321254A (el)
EP (1) EP0049135B1 (el)
JP (1) JPS5785370A (el)
AT (1) ATE7024T1 (el)
DE (1) DE3163096D1 (el)
DK (1) DK420781A (el)
GR (1) GR75053B (el)
IE (1) IE51596B1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
ZA804670B (en) * 1979-08-03 1981-07-29 Beecham Group Ltd Derivatives of clavulanic acid, a process for their preparation and their use
NZ199061A (en) * 1980-12-09 1984-10-19 Beecham Group Ltd 9-(n-tetrazolyl)-deoxyclavulanic acids,salts,esters,and pharmaceutical compositions
US4562182A (en) * 1980-12-23 1985-12-31 Beecham Group P.L.C. Compounds containing beta-lactams
US4350698A (en) * 1981-09-25 1982-09-21 Smithkline Corporation Antiallergic imidosulfamides
WO1988003137A1 (en) * 1986-10-28 1988-05-05 Smith Kline & French Laboratories Limited Tetrahydroisoquinolin-2-yl derivatives of carboxylic acids as thromboxane a2 antagonists
GB8717374D0 (en) * 1987-07-22 1987-08-26 Smith Kline French Lab Pharmaceutically active compounds
WO1999016752A1 (en) * 1997-09-30 1999-04-08 Molecular Designs International, Inc. β3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF USING
US6593341B2 (en) 2001-03-29 2003-07-15 Molecular Design International, Inc. β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
GB0210762D0 (en) * 2002-05-10 2002-06-19 Glaxo Group Ltd Compounds
US6596734B1 (en) 2002-10-11 2003-07-22 Molecular Design International, Inc. Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE24763E (en) 1960-01-12 Ch ch j
US3549640A (en) * 1967-11-03 1970-12-22 Mallinckrodt Chemical Works N-alkylsulfinylalkyl- and sulfonylalkyl-1,2,3,4-tetrahydroisoquinolines
GB1384530A (en) * 1971-07-29 1975-02-19 Fisons Ltd Chromone derivatives
AT352135B (de) * 1975-07-30 1979-09-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer homophthalimide und ihrer salze
DE2734222A1 (de) * 1977-07-29 1979-02-15 Thomae Gmbh Dr K Neue schwefelhaltige isochinolindione
US4252818A (en) * 1979-08-02 1981-02-24 Merck & Co., Inc. Novel benzopyran derivatives

Also Published As

Publication number Publication date
US4321254A (en) 1982-03-23
EP0049135A1 (en) 1982-04-07
EP0049135B1 (en) 1984-04-11
IE51596B1 (en) 1987-01-21
IE812228L (en) 1982-03-26
DE3163096D1 (de) 1984-05-17
JPS5785370A (en) 1982-05-28
ATE7024T1 (de) 1984-04-15
DK420781A (da) 1982-03-27

Similar Documents

Publication Publication Date Title
ES8207145A1 (es) Procedimiento para la preparacion de imidosulfamidas antia- lergicas
NO842340L (no) Fremgangsmaate og sammensetninger for frakturering av underjordiske formasjoner
DE3880047D1 (de) Zusammensetzung eines zusatzes.
NO901141L (no) Additiv og fremgangsmaate for behandling av underjordiske formasjoner.
IE812228L (en) Imidodisulfamides
JPS5721372A (en) Imidodisulfamide antiallergic
ATE7138T1 (de) Verfahren zur herstellung von 1,5-didesoxy-1,5imino-d-glucitol und dessen n-derivaten.
PT87618A (pt) Process for the preparation of polymeric hinderd amine light stabilizers and organic compositions therewith
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
OA09135A (fr) Procédés de préparation de ((Diarylméthoxy) alcoyl)- 1 pyrrolidines et pipéridines.
DK39084D0 (da) 2-imino-pyrrolidiner, fremgangsmade til deres fremstilling og terapeutiske midler indeholdende dem
ES2119874T3 (es) Nuevos derivados de elipticina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
JPS56127362A (en) N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1- alkane amine and beta-adrenalin functional nerve interrupting agent
IE820002L (en) Imidodisulfamides
GR77599B (el)
DK351484D0 (da) Pyrazolo(3,4,5-kl)acridinforbindelser, deres fremstilling og anvendelse
GEP19970662B (en) Method of alkylanilinofumarate synthesis
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
NO168704C (no) Analogifremgangsmaate for fremstilling av di-t-butylfenylalkyl og benzylethere.
ATE87314T1 (de) Platin-arzneimittel.
ES532644A0 (es) N-oxidos de derivados aminociclicos
PT88576A (pt) Process for the manufacture of pyrrolo <1,2-b>cinnolines and ofpharmaceutical compositions containing them
SU602860A1 (ru) Способ исследовани функции желудка
DE3269425D1 (en) Process for the treatment of organic amine compositions
KR890013698U (ko) 가스레인지의 안전차단회로